What is the registration number for SUMMIT STUDYING NMDA AND SIGMA-1 IN SMOKING CESSATION TREATMENT?

SUMMIT STUDYING NMDA AND SIGMA-1 IN SMOKING CESSATION TREATMENT is registered under USPTO registration number 0.

SUM

USPTO Trademark Record

PENDING

SUMMIT STUDYING NMDA AND SIGMA-1 IN SMOKING CESSATION TREATMENT

Q: Who owns the SUMMIT STUDYING NMDA AND SIGMA-1 IN SMOKING CESSATION TREATMENT trademark?

The SUMMIT STUDYING NMDA AND SIGMA-1 IN SMOKING CESSATION TREATMENT trademark is owned by Axsome Therapeutics, Inc..

Q: What class is the SUMMIT STUDYING NMDA AND SIGMA-1 IN SMOKING CESSATION TREATMENT trademark registered in?

The SUMMIT STUDYING NMDA AND SIGMA-1 IN SMOKING CESSATION TREATMENT trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

Q: What is the serial number for SUMMIT STUDYING NMDA AND SIGMA-1 IN SMOKING CESSATION TREATMENT?

The USPTO serial number for SUMMIT STUDYING NMDA AND SIGMA-1 IN SMOKING CESSATION TREATMENT is 50087189.

SN 50087189·Reg 0·Filed Sep 02, 2026

Owner Axsome Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

SUMMIT STUDYING NMDA AND SIGMA-1 IN SMOKING CESSATION TREATMENT (Serial No. 50087189), Registration No. 0, is a pending US trademark filed on Sep 02, 2026 by Axsome Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

SUMMIT STUDYING NMDA AND SIGMA-1 IN SMOKING CESSATION TREATMENT (Reg. #0) is a pending US trademark that was filed in 2026 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Sep 02, 2026

SERIAL

50087189

REG#

Owner

Applicant

Axsome Therapeutics, Inc.

Entity

Corporation

State

Address

One World Trade Center, 29th Floor, New York, NY, 10007

Country

Attorney

NameBrent A. Johnson

Law firm

Brent A. Johnson Procopio, Cory, Hargreaves & Savitch LLP

Docket

134057-064US001

Address

525 B Street, Suite 2200, San Diego, CA 92101, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateSep 02, 2026

Serial Number50087189

Registration No.0

Status DateOct 06, 2026

Mark TypeDesign with words

Attorney Docket134057-064US001

Status DescriptionLive and pending, approved for publication

Filing Signals

FILED

2026

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

9 events

EXAMINERS AMENDMENT -WRITTEN

Oct 06, 2026

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Oct 06, 2026

EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Oct 06, 2026

EXAMINER'S AMENDMENT ENTERED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Oct 06, 2026

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 06, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Oct 05, 2026

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 04, 2026

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 02, 2026

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Sep 02, 2026

APPLICATION FILING RECEIPT MAILED

SUMMIT STUDYING NMDA AND SIGMA-1 IN SMOKING CESSATION TREATMENT

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Axsome Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Brent A. Johnson

Resources

Company